Ligand-based Molecular Modeling of HDL Receptor SR-BI Inhibitors as Potent Anti-hyperlipidemic Agents

References

1. ShahA.M. BanerjeeT. MukherjeeD. Coronary, peripheral and cerebrovascular disease: A complex relationship.J. Indian Med. Assoc.2010108529229421121404
   [Google Scholar]
2. RossR. Atherosclerosis--an inflammatory disease.N. Engl. J. Med.1999340211512610.1056/NEJM1999011434002079887164
   [Google Scholar]
3. CleemanJ.I. LenfantC. The national cholesterol education program.J. Am. Diet. Assoc.198888111401140810.1016/S0002‑8223(21)08024‑X3183260
   [Google Scholar]
4. Gillotte-TaylorK. BoullierA. WitztumJ.L. SteinbergD. QuehenbergerO. Scavenger receptor class B type I as a receptor for oxi-dized low density lipoprotein.J. Lipid Res.20014291474148210.1016/S0022‑2275(20)30281‑911518768
   [Google Scholar]
5. ActonS.L. KozarskyK.F. RigottiA. The HDL receptor SR-BI: A new therapeutic target for atherosclerosis?Mol. Med. Today199951251852410.1016/S1357‑4310(99)01600‑710562717
   [Google Scholar]
6. StanglH. StroblW.M. Role of SR-BI in HDL Metabolism.The HDL Handbook2017171185
   [Google Scholar]
7. NielandT.J.F. ShawJ.T. JaipuriF.A. MaligaZ. DuffnerJ.L. KoehlerA.N. KriegerM. Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI.J. Lipid Res.20074881832184510.1194/jlr.M700209‑JLR20017533223
   [Google Scholar]
8. RosensonR.S. BrewerH.B.Jr DavidsonW.S. FayadZ.A. FusterV. GoldsteinJ. HellersteinM. JiangX.C. PhillipsM.C. RaderD.J. RemaleyA.T. RothblatG.H. TallA.R. Yvan-CharvetL. Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport.Circulation2012125151905191910.1161/CIRCULATIONAHA.111.06658922508840
   [Google Scholar]
9. DockendorffC. FaloonP.W. YuM. YoungsayeW. PenmanM. NielandT.J.F. NagP.P. LewisT.A. PuJ. BennionM. NegriJ. PatersonC. LamG. DandapaniS. PerezJ.R. MunozB. PalmerM.A. SchreiberS.L. KriegerM. Indolinyl-thiazole based inhibitors of scavenger receptor-BI (SR-BI)-mediated lipid transport.ACS Med. Chem. Lett.20156437538010.1021/ml500154q26478787
   [Google Scholar]
10. KubinyiH. Evolutionary variable selection in regression and PLS analyses.J. Chemometr.199610211913310.1002/(SICI)1099‑128X(199603)10:2<119::AID‑CEM409>3.0.CO;2‑4
    [Google Scholar]
11. SadowskiJ. GasteigerJ. From atoms and bonds to three-dimensional atomic coordinates: automatic model builders.Chem. Rev.1993932567258110.1021/cr00023a012
    [Google Scholar]
12. TodeschiniV. Handbook of molecular descriptors.WeinheimWiley-VCH200010.1002/9783527613106
    [Google Scholar]
13. KarelsonM. Molecular Descriptors in QSAR/QSPR.New YorkJohn Wiley & Sons2000
    [Google Scholar]
14. M.M. C. Multivariate QSAR.J. Braz. Chem. Soc.200213742753
    [Google Scholar]
15. KowalskiB.R. BenderC.F. Pattern recognition. II. Linear and nonlinear methods for displaying chemical data.J. Am. Chem. Soc.197395368669310.1021/ja00784a007
    [Google Scholar]
16. WorldS. JohanssonE. CocchiM. PLS-partial least squares projections to latent str. In: 3D-QSAR in Drug Design, Theory, Methods, and Applications. KubinyiH. LeidenESCOM Science Publishers1993523550
    [Google Scholar]
17. TetkoI.V. LuikA.I. PodaG.I. Applications of neural networks in structure-activity relationships of a small number of molecules.J. Med. Chem.199336781181410.1021/jm00059a0038464034
    [Google Scholar]
18. McFarlandJ.W. GansD.J. Cluster significance analysis contrasted with three other quantitative structure-activity relationship methods.J. Med. Chem.1987301464910.1021/jm00384a0083806603
    [Google Scholar]
19. WorldS. ErikssonL. Statistical validation of QSAR results.Chemometric methods in molecular design.New YorkVCH1995309318
    [Google Scholar]